Novavax Porks Swine Flu (NVAX)

Posted in pre-market 
December 2nd, 2009

Novavax, Inc. (NASDAQ: NVAX) is trading up again on swine flu or H1N1 news.  The company issued a press release showing positive clinical results from a pivotal study of H1N1 influenza vaccine in Mexico.  At 8:21 AM EST we have seen 319,000 shares trade hands and the stock is up 7.1% at $3.44.  Average volume is now over 5 million shares and the 52-week trading range is $0.52 to $7.79.

Jon C. Ogg

Comments are closed

-->